ACE and cancer: Assessment of troponin-T helps to identify patients with cardiotoxicity during cancer therapy (35), and preventative therapy with β-blocker and angiotensin converting enzyme inhibitor/angiotensin II receptor blocker were associated with less cardiac troponin-T elevation in cancer patients (36).